DMD and Duchenne muscular dystrophy: Together these results validated the two DMD minigene constructs, in that they could mimic the phenomena of endogenous exon skipping reported in DMD patients with stop codon mutations, and that they could be used to identify small molecule and genetic regulators of these endogenous processes without having to artificially induce the process with high levels of AON.